Cargando…
Enhanced tyrosine sulfation is associated with chronic kidney disease-related atherosclerosis
BACKGROUND: Chronic kidney disease (CKD) accelerates atherosclerosis, but the mechanisms remain unclear. Tyrosine sulfation has been recognized as a key post-translational modification (PTM) in regulation of various cellular processes, and the sulfated adhesion molecules and chemokine receptors have...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332009/ https://www.ncbi.nlm.nih.gov/pubmed/37424015 http://dx.doi.org/10.1186/s12915-023-01641-y |
_version_ | 1785070354540003328 |
---|---|
author | Dai, Daopeng Zhu, Zhengbin Han, Hui Xu, Tian Feng, Shuo Zhang, Wenli Ding, Fenghua Zhang, Ruiyan Zhu, Jinzhou |
author_facet | Dai, Daopeng Zhu, Zhengbin Han, Hui Xu, Tian Feng, Shuo Zhang, Wenli Ding, Fenghua Zhang, Ruiyan Zhu, Jinzhou |
author_sort | Dai, Daopeng |
collection | PubMed |
description | BACKGROUND: Chronic kidney disease (CKD) accelerates atherosclerosis, but the mechanisms remain unclear. Tyrosine sulfation has been recognized as a key post-translational modification (PTM) in regulation of various cellular processes, and the sulfated adhesion molecules and chemokine receptors have been shown to participate in the pathogenesis of atherosclerosis via enhancement of monocyte/macrophage function. The levels of inorganic sulfate, the essential substrate for the sulfation reaction, are dramatically increased in patients with CKD, which indicates a change of sulfation status in CKD patients. Thus, in the present study, we detected the sulfation status in CKD patients and probed into the impact of sulfation on CKD-related atherosclerosis by targeting tyrosine sulfation function. RESULTS: PBMCs from individuals with CKD showed higher amounts of total sulfotyrosine and tyrosylprotein sulfotransferase (TPST) type 1 and 2 protein levels. The plasma level of O-sulfotyrosine, the metabolic end product of tyrosine sulfation, increased significantly in CKD patients. Statistically, O-sulfotyrosine and the coronary atherosclerosis severity SYNTAX score positively correlated. Mechanically, more sulfate-positive nucleated cells in peripheral blood and more abundant infiltration of sulfated macrophages in deteriorated vascular plaques in CKD ApoE null mice were noted. Knockout of TPST1 and TPST2 decreased atherosclerosis and peritoneal macrophage adherence and migration in CKD condition. The sulfation of the chemokine receptors, CCR2 and CCR5, was increased in PBMCs from CKD patients. CONCLUSIONS: CKD is associated with increased sulfation status. Increased sulfation contributes to monocyte/macrophage activation and might be involved in CKD-related atherosclerosis. Inhibition of sulfation may suppress CKD-related atherosclerosis and is worthy of further study. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12915-023-01641-y. |
format | Online Article Text |
id | pubmed-10332009 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-103320092023-07-11 Enhanced tyrosine sulfation is associated with chronic kidney disease-related atherosclerosis Dai, Daopeng Zhu, Zhengbin Han, Hui Xu, Tian Feng, Shuo Zhang, Wenli Ding, Fenghua Zhang, Ruiyan Zhu, Jinzhou BMC Biol Research Article BACKGROUND: Chronic kidney disease (CKD) accelerates atherosclerosis, but the mechanisms remain unclear. Tyrosine sulfation has been recognized as a key post-translational modification (PTM) in regulation of various cellular processes, and the sulfated adhesion molecules and chemokine receptors have been shown to participate in the pathogenesis of atherosclerosis via enhancement of monocyte/macrophage function. The levels of inorganic sulfate, the essential substrate for the sulfation reaction, are dramatically increased in patients with CKD, which indicates a change of sulfation status in CKD patients. Thus, in the present study, we detected the sulfation status in CKD patients and probed into the impact of sulfation on CKD-related atherosclerosis by targeting tyrosine sulfation function. RESULTS: PBMCs from individuals with CKD showed higher amounts of total sulfotyrosine and tyrosylprotein sulfotransferase (TPST) type 1 and 2 protein levels. The plasma level of O-sulfotyrosine, the metabolic end product of tyrosine sulfation, increased significantly in CKD patients. Statistically, O-sulfotyrosine and the coronary atherosclerosis severity SYNTAX score positively correlated. Mechanically, more sulfate-positive nucleated cells in peripheral blood and more abundant infiltration of sulfated macrophages in deteriorated vascular plaques in CKD ApoE null mice were noted. Knockout of TPST1 and TPST2 decreased atherosclerosis and peritoneal macrophage adherence and migration in CKD condition. The sulfation of the chemokine receptors, CCR2 and CCR5, was increased in PBMCs from CKD patients. CONCLUSIONS: CKD is associated with increased sulfation status. Increased sulfation contributes to monocyte/macrophage activation and might be involved in CKD-related atherosclerosis. Inhibition of sulfation may suppress CKD-related atherosclerosis and is worthy of further study. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12915-023-01641-y. BioMed Central 2023-07-10 /pmc/articles/PMC10332009/ /pubmed/37424015 http://dx.doi.org/10.1186/s12915-023-01641-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Dai, Daopeng Zhu, Zhengbin Han, Hui Xu, Tian Feng, Shuo Zhang, Wenli Ding, Fenghua Zhang, Ruiyan Zhu, Jinzhou Enhanced tyrosine sulfation is associated with chronic kidney disease-related atherosclerosis |
title | Enhanced tyrosine sulfation is associated with chronic kidney disease-related atherosclerosis |
title_full | Enhanced tyrosine sulfation is associated with chronic kidney disease-related atherosclerosis |
title_fullStr | Enhanced tyrosine sulfation is associated with chronic kidney disease-related atherosclerosis |
title_full_unstemmed | Enhanced tyrosine sulfation is associated with chronic kidney disease-related atherosclerosis |
title_short | Enhanced tyrosine sulfation is associated with chronic kidney disease-related atherosclerosis |
title_sort | enhanced tyrosine sulfation is associated with chronic kidney disease-related atherosclerosis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332009/ https://www.ncbi.nlm.nih.gov/pubmed/37424015 http://dx.doi.org/10.1186/s12915-023-01641-y |
work_keys_str_mv | AT daidaopeng enhancedtyrosinesulfationisassociatedwithchronickidneydiseaserelatedatherosclerosis AT zhuzhengbin enhancedtyrosinesulfationisassociatedwithchronickidneydiseaserelatedatherosclerosis AT hanhui enhancedtyrosinesulfationisassociatedwithchronickidneydiseaserelatedatherosclerosis AT xutian enhancedtyrosinesulfationisassociatedwithchronickidneydiseaserelatedatherosclerosis AT fengshuo enhancedtyrosinesulfationisassociatedwithchronickidneydiseaserelatedatherosclerosis AT zhangwenli enhancedtyrosinesulfationisassociatedwithchronickidneydiseaserelatedatherosclerosis AT dingfenghua enhancedtyrosinesulfationisassociatedwithchronickidneydiseaserelatedatherosclerosis AT zhangruiyan enhancedtyrosinesulfationisassociatedwithchronickidneydiseaserelatedatherosclerosis AT zhujinzhou enhancedtyrosinesulfationisassociatedwithchronickidneydiseaserelatedatherosclerosis |